The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 6.00
Ask: 6.40
Change: -0.10 (-1.59%)
Spread: 0.40 (6.667%)
Open: 6.30
High: 6.30
Low: 6.20
Prev. Close: 6.30
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kromek Awarded $58m Medical Imaging Contract

28 Jan 2019 07:00

RNS Number : 2050O
Kromek Group PLC
28 January 2019
 

28 January 2019 

 

Kromek Group plc

("Kromek" or the "Company")

 

Kromek Awarded $58m Medical Imaging Contract

New significant multi-year contract for supply of CZT detectors to OEM customer

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce that it has been awarded a new contract, by an existing OEM customer, expected to be worth a minimum of $58.1m over a seven-year period.

 

Under the terms of the contract, Kromek will supply Cadmium Zinc Telluride (CZT) detectors and associated advanced electronics to be used in state-of-the-art medical imaging systems. The Company's technology provides higher resolution detection capabilities enabling better patient outcomes.

 

Kromek will deliver the contract over a seven-year period, commencing immediately, and will begin recognising revenue from the 2019/2020 fiscal year.

 

Arnab Basu, CEO of Kromek, commented: "We are delighted to have been awarded this multi-year contract from an existing OEM customer, which is one of the most significant that we have secured both from a strategic and monetary perspective. It is also the first major contract that will be delivered from our new facility in the US that has been purpose built as a world-class production site for medical imaging products.

 

"Building on the $80m of contracts won over the last three fiscal years, this award strengthens and solidifies our revenue visibility and demonstrates the increasing commercial traction of our CZT detectors in our key target markets of medical imaging and nuclear detection."

 

 

This announcement contains inside information.

 

For further information, please contact:

 

Kromek Group plc

Arnab Basu, CEO

Derek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Max Hartley (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Cantor Fitzgerald Europe (Joint Broker)

Philip Davies

Will Goode

 

+44 (0)20 7894 7000

Luther Pendragon Ltd (PR)

Harry Chathli

Claire Norbury

Alexis Gore

+44 (0)20 7618 9100

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTBRMTTMBJTTJL
Date   Source Headline
27th Nov 20137:00 amRNSBottle Scanner Orders and New Accreditation
5th Nov 20137:00 amRNSOrders and payments received from global OEMs
31st Oct 20131:28 pmRNSTotal Voting Rights
24th Oct 201311:44 amRNSHolding(s) in Company
21st Oct 20136:08 pmRNSHolding(s) in Company
16th Oct 20137:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.